Yarward Electronics (Shandong) Co (301337) Fair Value & Analysis
Healthcare · CN · Market cap 2.9B CNY
Fair value as of: Jul 9, 2026
From 2 valuation models · updated 32 days ago
Fair value updated Jul 9, 2026, revised from ¥47.10 to ¥8.18 (−82.6%) since Jun 24, 2026. Share price −3.6% over the past month.
Below-average quality, and screening another 68% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥8.56). The favourable scenario is already priced in.
- Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- The models converge in a tight band (¥7.79 to ¥8.56), unusually little disagreement for a valuation.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
39‑month range ¥21.01 – ¥55.39 · fair‑value band ¥7.79 – ¥8.56 · the ¥25.21 price screens above the ¥8.18 fair value. Dashed = 300-day average. As of Jul 9, 2026.
Analysis
Yarward Electronics (Shandong) Co (301337) currently trades at ¥25.21, while our model-based Fair Value estimate is ¥8.18, implying the stock looks roughly 67.6% overvalued today. The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Yarward Electronics (Shandong) Co generated revenue of 253M CNY at a net margin of -7.0%. Revenue declined 2.6% year over year. It earns a return on equity of -1.8%. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥7.79 (bear case) to ¥8.56 (bull case); at ¥25.21, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at -68%, 301337 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Multiples (¥8.18) versus Asset-Based (¥7.01). Highest evidence: EV/EBITDA (54).
Notify me when 301337 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 44 · Market factors (momentum, volatility) 35
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Yarward Electronics (Shandong) Co., Ltd. engages in the research, development, production, and sale of hospital intelligent communication interactive systems in China and internationally.
Full company description
Yarward Electronics (Shandong) Co., Ltd. engages in the research, development, production, and sale of hospital intelligent communication interactive systems in China and internationally. The company offers smart ward, including healthcare communication, remote visiting and ICU guarding, and wireless communication, hospital life service, and surgical collaboration systems; smart clinic, such as triage calling, information publishing, self-service, and map guidance systems; smart eldercare comprising smart eldercare management, smart healthcare communication, and wireless positioning call systems; and smart IoT, which includes positioning sensing system. It also provides smart ward integrated platform, and intelligent healthcare communication and smart ward overall solutions; outpatient queuing and information display system solutions; intelligent nursing communication system solutions; wireless healthcare communication and indoor positioning sensing system solutions; visitation and guarding system solutions; and smart OR solution. The company was founded in 1998 and is headquartered in Zibo, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Yarward Electronics (Shandong) Co reported revenue of ¥254M in FY2025 versus ¥288M in FY2021, a compound −3.0%/yr. Reported net income was −¥14.8M in FY2025.
301337 screens 68% overvalued. Compare with Veeva Systems Inc →
Peer Group
Health Information Services · 126 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare Yarward Electronics (Shandong) Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Yarward Electronics (Shandong) Co (301337) overvalued or undervalued?
What is the fair value of 301337?
What is the quality score of 301337?
What is the revenue of Yarward Electronics (Shandong) Co (301337)?
What is the net profit margin of 301337?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Yarward Electronics (Shandong) Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.